Epidemiological characteristics and prognostic factors of post-traumatic endophthalmitis.


Journal

The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411

Informations de publication

Date de publication:
Feb 2022
Historique:
entrez: 4 2 2022
pubmed: 5 2 2022
medline: 8 2 2022
Statut: ppublish

Résumé

To examine the prognostic factors and features of post-traumatic endophthalmitis. This retrospective study enrolled adult patients (>18 years old) diagnosed with post-traumatic endophthalmitis. Their medical records were reviewed and the patient demographic characteristics, features of injury, management, outcomes and microbiology data were analysed. A total of 131 eyes from 131 patients were enrolled. Post-traumatic endophthalmitis was more common in male patients (122 of 131 patients: 93.1%), in those aged 30-44 years (51 of 131 patients: 38.9%), in those injured with a metallic object (86 of 131 patients; 65.6%), in those with a penetrating injury (90 of 131 patients; 68.7%) and those that were injured at work (106 of 131 patients; 80.9%). The mean ± SD time of presentation to the hospital and developing endophthalmitis was 40.60 ± 19.32 h and 5.19 ± 2.55 days, respectively. Of the cultures, 84 of 131 (64.1%) were negative and 22 of 131 (16.8%) were positive for Immediate presentation to an ophthalmic centre and timely diagnosis and intervention may lead to better outcomes.

Identifiants

pubmed: 35114823
doi: 10.1177/03000605211070754
pmc: PMC8819759
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3000605211070754

Références

Ophthalmologica. 2010;224(2):79-85
pubmed: 19707031
Arch Ophthalmol. 2007 Apr;125(4):460-5
pubmed: 17420365
Int Ophthalmol. 2001;24(6):323-30
pubmed: 14750569
Ophthalmology. 1987 Apr;94(4):407-13
pubmed: 3495766
Am J Ophthalmol. 1995 Feb;119(2):181-8
pubmed: 7832224
Br J Ophthalmol. 2010 Jan;94(1):111-4
pubmed: 19692359
Eye (Lond). 2012 Feb;26(2):212-7
pubmed: 22134598
Ophthalmology. 1988 Jul;95(7):911-6
pubmed: 3262852
Ophthalmology. 1990 Nov;97(11):1532-8
pubmed: 2255525
Am J Ophthalmol. 2002 Jan;133(1):62-9
pubmed: 11755840
Indian J Ophthalmol. 2006 Mar;54(1):5-10
pubmed: 16531663
Klin Monbl Augenheilkd. 2004 Aug;221(8):629-35
pubmed: 15343446
Am J Ophthalmol. 1997 Jun;123(6):820-31
pubmed: 9535627
Curr Opin Ophthalmol. 1997 Jun;8(3):32-8
pubmed: 10168892
Surv Ophthalmol. 1999 Nov-Dec;44(3):215-25
pubmed: 10588440
Retina. 2012 Jan;32(1):146-51
pubmed: 21775927
Arch Ophthalmol. 2001 May;119(5):754-5
pubmed: 11346404
Arch Ophthalmol. 1984 Apr;102(4):547-50
pubmed: 6704010
Am J Ophthalmol. 1999 Aug;128(2):242-4
pubmed: 10458188
Eur J Ophthalmol. 2007 Jul-Aug;17(4):642-7
pubmed: 17671943
Br J Ophthalmol. 1987 Aug;71(8):614-7
pubmed: 3498510
Eye (Lond). 2008 Jan;22(1):13-7
pubmed: 16751752
Acta Ophthalmol. 2013 Aug;91(5):475-82
pubmed: 22313810
Ophthalmology. 2004 Nov;111(11):2015-22
pubmed: 15522366
Ophthalmology. 2000 May;107(5):823-8
pubmed: 10811069
Surv Ophthalmol. 2011 May-Jun;56(3):214-51
pubmed: 21397289
Bull World Health Organ. 2007 Nov;85(11):867-72
pubmed: 18038077
Semin Ophthalmol. 2015;30(5-6):470-4
pubmed: 24571685
J Ophthalmic Inflamm Infect. 2014 Feb 18;4(1):5
pubmed: 24548669
Semin Ophthalmol. 2018;33(2):284-292
pubmed: 27929716
Arch Ophthalmol. 2006 Feb;124(2):178-82
pubmed: 16476886

Auteurs

Bahram Bohrani Sefidan (B)

Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Seyed Ali Tabatabaei (SA)

Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Soleimani (M)

Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Aliasghar Ahmadraji (A)

Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mansoor Shahriari (M)

Imam Hossein Medical Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mostafa Daraby (M)

Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Amin Dehghani Sanij (A)

Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Ali Mehrakizadeh (A)

Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Bahareh Ramezani (B)

School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Kasra Cheraqpour (K)

Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH